Testing can make all the difference
COVIDSeq, the first diagnostic NGS test to receive emergency use authorization from the FDA.
在冠状病毒的测序中，Chiu博士可能掌握了疾病的关键信息
当UCSF的Charles Chiu被CDC选中来对整个州的病毒株进行测序时，他知道自己需要更大的力量。
Bedford博士帮助追踪和阻止华盛顿的社区传播
借助Illumina NextSeq 550和试剂，Bedford博士鉴定了出美国第一批COVID-19聚集性感染之一。
新一代测序如何帮助鉴别和追踪SARS-CoV-2
Illumina已经建立了两套工作流程，从临床样本中检测和追踪SARS-CoV-2
NGS的力量：从病毒鉴定到疫苗开发再到疫情控制
新一代测序（NGS）具有独特的能力，能够为一线的科学家、研究人员、公共卫生人员和医护专业人员提供支持。它可以帮助我们了解传播途径、并发症、突变率，为疫苗开发和治疗奠定基础，并最终帮助预测和预防未来的疫情爆发。
通过CMO Phil Febbo，了解更多信息
以支持全球需求为己任
我们是一家维护全人类利益的全球性公司，致力于在全球范围内支持抗击COVID-19。我们很荣幸能与合作伙伴共同资助非洲传染性疾病基因组卓越中心（Africa Centre of Excellence for Genomics of Infectious Diseases）和米尔肯研究所，发展全球监测网络。
查看COVID-19相关案例
我们独特的支持能力
凭借我们几十年的经验、广泛的全球覆盖范围、各国和各种语言的支持以及数据透明度，我们得以迅速连接和支持地方和全球的资源，帮助人们在全球范围内抗击疫情。
How We Support the Fight Against COVID-19
Global
Illumina makes software toolkit available free of charge to support worldwide efforts to combat COVID-19
Read MoreAfrica
An Illumina Donation to the African CDC Expands their Capability for Sequencing-Based Surveillance
Read MoreChina
Providing the system used to sequence the first SARS-CoV-2 genome in Wuhan
Cambodia
iSeq 100 System + iSeq cloud metagenomic platform allow characterization of SARS-CoV-2 in Cambodia
Read MoreIllumina COVID-19检测工作流程
管理工作流程
制备文库
测序
分析
合作
Key Solutions
Shotgun Metagenomics
Allows researchers to identify novel pathogens and helps accelerate outbreak investigations.
Respiratory Pathogen Enrichment
Detects SARS-CoV-2 as well as common respiratory pathogens, and provides information about epidemiology and evolution.
Illumina COVIDSeq Test
This high-throughput NGS test detects RNA from the SARS-CoV-2 virus.
Join the conversation
Register now for a conversation with former U.S. FDA Commissioner Dr. Scott Gottlieb: “Genomics’ Role in Global COVID-19 Surveillance”.
Register Now
COVID-19相关资源
- www.cdc.gov/coronavirus/2019-ncov/communication/guidance-list.html
- www.coronavirus.gov
- www.mayoclinichealthsystem.org/covid19
- www.nih.gov/health-information/coronavirus
- www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-emergency-use-authorizations-euas-medical-devices-during-covid-19-pandemic